Zealand Pharma A/S (ZLDPF)
OTCMKTS
· Delayed Price · Currency is USD
67.62
-1.70 (-2.45%)
May 28, 2025, 1:34 PM EDT
Zealand Pharma Revenue
Zealand Pharma had revenue of 8.09M DKK in the quarter ending March 31, 2025, a decrease of -46.37%. This brings the company's revenue in the last twelve months to 55.69M, down -83.82% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.
Revenue (ttm)
55.69M DKK
Revenue Growth
-83.82%
P/S Ratio
601.86
Revenue / Employee
166.25K DKK
Employees
335
Market Cap
4.86B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
Zealand Pharma News
- 2 days ago - European stocks edge higher after Trump delays 50% tariffs on EU - CNBC
- 2 days ago - European stocks recover after Trump delays EU tariffs in hopes of deal - Reuters
- 9 days ago - Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer - GlobeNewsWire
- 12 days ago - Zealand: Promising Roche-Partnered Obesity Drug Developer - But Stock Is Pricey - Seeking Alpha
- 16 days ago - Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 - GlobeNewsWire
- 19 days ago - Zealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Zealand Pharma announces closing of collaboration and license agreement with Roche - GlobeNewsWire
- 20 days ago - Zealand Pharma A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha